Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1010-1015
Published online before print February 23, 2006, doi: 10.1161/01.STR.0000206439.62025.97
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/4/1010    most recent
01.STR.0000206439.62025.97v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silvestrini, M.
Right arrow Articles by Vernieri, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silvestrini, M.
Right arrow Articles by Vernieri, F.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Alzheimer's Disease
Related Collections
Right arrow Other diagnostic testing
Right arrow Brain Circulation and Metabolism
Right arrow Doppler ultrasound, Transcranial Doppler etc.

(Stroke. 2006;37:1010.)
© 2006 American Heart Association, Inc.


Original Contributions

Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease

Mauro Silvestrini, MD; Patrizio Pasqualetti, PhD; Roberto Baruffaldi, MD; Marco Bartolini, MD; Yasmin Handouk, MD; Maria Matteis, PhD; Filomena Moffa, PhD; Leandro Provinciali, MD Fabrizio Vernieri, MD

From the Neurological Clinic (M.S., R.B., M.B., Y.H., L.P.), Polytechnic University of Marche, Ancona, Italy; Department of Neuroscience (P.P., F.M.), AfaR-Fatebenefratelli Hospital, Isola Tiberina, Roma, Italy; IRCCS Fondazione Santa Lucia (M.M.), Roma, Italy; and Neurological Clinic (F.V.), Campus Biomedico University, Roma, Italy.

Correspondence to Professor Mauro Silvestrini, Clinica Neurologica, Università Politecnica delle Marche, Via Conca 71, 60020 Ancona, Italy. E-mail masilvestrini{at}libero.it

Background and Purpose— The aim of this study was to explore the possible contribution of alterations in cerebral hemodynamics to the evolution of cognitive impairment in patients with Alzheimer disease (AD).

Method— Fifty-three patients with AD were investigated. The evolution of cognitive decline over 12 months was evaluated by means of changes in Mini Mental State Examination (MMSE) and AD Assessment Scale for Cognition (ADAS-Cog) scores. Demographic characteristics, vascular risk profile, pharmacological treatment, and presence of white matter lesions were assessed at entry. Further, a basal evaluation of cerebrovascular reactivity to hypercapnia was measured with transcranial Doppler ultrasonography using the breath-holding index (BHI).

Results— Of all the variables considered, both MMSE and ADAS-Cog changes had the highest correlation with BHI, followed by age and diabetes. After subdividing both cognitive measures reductions into bigger and smaller-than-average decline (2 points for MMSE; 5 points for ADAS-Cog), multiple logistic regression indicated BHI as the sole significant predictor of cognitive decline.

Conclusions— These results show an association between impaired cerebral microvessels functionality and unfavorable evolution of cognitive function in patients with AD. Further research is needed to fully establish whether altered cerebral hemodynamics may be considered an independent factor in sustaining cognitive decline progression or an effect of pathological processes involved in AD.


Key Words: dementia • hemodynamics • ultrasonography • ultrasonography, Doppler, transcranial




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al.
Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein
PNAS, January 29, 2008; 105(4): 1347 - 1352.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. M. Mielke, P. B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, K. M. Hayden, M. Norton, P. V. Rabins, R. C. Green, K. A. Welsh-Bohmer, et al.
Vascular factors predict rate of progression in Alzheimer disease
Neurology, November 6, 2007; 69(19): 1850 - 1858.
[Abstract] [Full Text] [PDF]